- Min.Order :1 Gram
- Purity: ≥ 98%
- Payment Terms : L/C,D/A,D/P,T/T,
Keywords
Eptifibatide 188627-80-7 Eptifibatide
Quick Details
- Appearance:White powder
- Application:Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.?
- PackAge:25 KG/Fiber Drum
- ProductionCapacity:100|Kilogram|Month
- Storage:2 ℃～8 ℃
- Transportation:By Ship or By Air
Superiority:
|
CAS No. |
188627-80-7 |
|
Molecular formula |
C35H49N11O9S2 |
|
Molecular weight |
831.96g/mol |
|
Appearance |
White Powder |
|
Purity |
≥ 98.0% |
|
Storage Condition |
2 ℃～8 ℃ |
|
specifications (powder) |
1g, 10g, 100g |
|
Packing |
Aluminum foil bag |
|
Application |
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity. |
Details:
Wuhan PharmChem CO., LTD offer a diverse selection of the chemicals used in the development and manufacturing on the following industries:
Pharma&Food Intermediates
Water Treatment Chemicals
Industrial Specialties
Fine Chemicals
Medical Materials & Accessories
Q1. How about your samples
Yes, we can serve you our samples for your test (Freight collect).
You also can get a refund of the freight cost when the bulk order is placed.
Q2. How much for the freight
It depends on your area, we will use DHL, FedEx and EMS bulk service, it had discount as normal express service. And we can return freight while you place order.
Q3. Do you have discount for large quantities
Yes, not only depends on your order quantity, but also the item you booked.
Q4. What about delivery
Prompt shipment after receipt of order confirmation for regular products.
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View